[Efficacy and tolerability of 5-aminosalicylic acid in the short-term treatment of ulcerative rectocolitis during the mild or moderate stage].
The aim of the study was to compare the efficacy and side-effects of 5-ASA and SASP in the treatment of active ulcerative colitis. An improvement was seen in 71.4% (5-ASA) and 70.3% (SASP) but there were no complete remissions. The incidence of improvements was only 36.3% (5-ASA) and 37.5% (SASP) in pancolitis. The side-effects appeared in 14.2% (5-ASA) and 21% (SASP).
Bresci
G
G
U.S.L. n. 12, Pisa, Divisione di Gastroenterologia.
Carrai
M
M
Venturini
G
G
Gambardella
L
L
D000328:Adult; D000368:Aged; D000636:Aminosalicylic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D019804:Mesalamine; D008875:Middle Aged; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects; D013997:Time Factors
D000636:Aminosalicylic Acids; D012460:Sulfasalazine; D019804:Mesalamine
Efficacia e tollerabilità dell'acido 5-aminosalicilico nel trattamento a breve termine della rettocolite ulcerosa in fase di attività lieve o media.